$52.37
0.500.96%
At close: Nov 13, 4:00 PM EST
$52.02
-0.35-0.67%
After Hours: Nov 13, 5:19 PM EST
GeneDx Holdings Corp
WGSNASDAQ
GeneDx fell 59.6% from $129.55 to $52.37, behind the S&P 500's +13.3%. Its worst day was May 5 (−49.2%), and its low came May 5 at $34.51.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
GeneDx closed at its highest level of the year, 29.3% above where the year started.
+4.0% · S&P 500 +0.9%
EPS of $0.14 beat the $0.12 estimate on $121.0M revenue (est. $119.9M); FY revenue guidance of $540.0M–$555.0M against the $536.4M consensus.
Story events cover the past 12 months · Times ET
+6.1% · S&P 500 −1.0%
EPS of $-0.28 missed the $-0.03 estimate on $102.3M revenue (est. $112.1M); FY revenue guidance of $475.0M–$490.0M against the $549.0M consensus.
−49.2%, the year's worst day, on 11M shares, the year's heaviest volume · S&P 500 +0.8%
EPS of $0.01 beat the $-0.19 estimate on $114.4M revenue (est. $110.7M); FY revenue guidance of $475.0M–$490.0M against the $477.1M consensus.
+4.5% · S&P 500 +1.8%
GeneDx shares fell 16.4%, while the S&P 500 fell 0.5%.
−16.4% · S&P 500 −0.5%
EPS of $0.28 beat the $0.07 estimate on $123.1M revenue (est. $122.8M); FY revenue guidance of $475.0M–$490.0M against the $481.1M consensus.
−16.6% · S&P 500 −0.4%
Where it ended: a close of $52.37 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 22, 2027 (EPS est. $0.05, revenue est. $123.6M).
Nothing in the past 12 months.
All WGS dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for WGS and SPY from Benzinga historical bars. Not investment advice.
